SRPT
NASDAQ
$16.83
Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $22.17 (+31.73%)
Market Cap
$1.86B
Revenue 5Y CAGR
+26.94%
P/E Ratio
4.88
Free Cash Flow Yield
6.18%
Price Chart
Valuation
Market Cap$1.86B
P/E4.88
Forward P/E5.01
PEG159.25
P/S0.87
P/B1.26
Profitability
Total Revenue (TTM)$1.58B
Gross Profit (TTM)$471M
EBITDA$4.17M
Profit Margin3%
Operating Margin49%
EPS$3.61
Financial Health
Debt-to-Equity55.7%
Free Cash Flow Yield6.18%
Growth & Risk
Revenue 5Y CAGR+26.94%
Beta (5Y)1.40
Sharpe Ratio0.15